Science

Nate is downgraded to a tropical depression after making US landfall twice

Read in app

Nate is expected to become a hurricane before it reaches the northern Gulf of Mexico. Forecasters caution that the strength and category of a storm are not necessarily reflective of the damage it can cause, as heavy rainfall and storm surge can be destructive even without extreme winds.

Nate adds yet another threat to what has already been an extremely active Atlantic hurricane season. It's the 14th named storm of the season, which doesn't end until late November.

So far this season, we've had eight hurricanes, five of which were major hurricanes — classified as Category 3 or above. If Nate's wind speeds pick up, it will be the ninth.

The western Caribbean, where Nate formed, is one of the main spots to watch for storms at this point in the season, according to Phil Klotzbach, a meteorologist at Colorado State University. Since 1851, 25% of Atlantic tropical storms, 33% of hurricanes, and 60% of major hurricanes in October have formed in that region.

Read next

Kevin was a correspondent covering science and health for Business Insider. He covered climate and the environment, infectious disease, the limits of human performance, and more.  He wrote four stories for Business Insider's "Saving our World" series, covering the steps humanity will have to take to adapt to the effects of climate change, the ways rising seas will affect cities like Miami, how scientists are devising ways to bring coral reefs back to life, and potential last-ditch geoengineering efforts. He covered ways that fasting could potentially slow aging and fight disease. He wrote a Tech Insider feature profiling a scientist who thinks he could have a cure for all viruses: This man's potentially huge medical breakthrough can't get funding, so he's trying something desperate. He also wrote a launch feature for Tech Insider on the ways humans are using new genetic editing tools to reshape our world: The age of genetically engineered animals has arrived. At Business Insider, he wrote one of the first stories investigating the blood-testing startup Theranos: Scientists are skeptical about the secret blood test that has made Elizabeth Holmes a billionaire. Before Business Insider, he studied health and science writing at the CUNY Graduate School of Journalism. Before that, he earned a B.A. in political science and philosophy from the University of Notre Dame. He spent several years traveling and has written for Condé Nast Traveler, The Christian Science Monitor, and other publications.